Emergency ambulatory outpatient management of immune-mediated hypophysitis

[1]  P. Lorigan,et al.  Emergency presentations in patients treated with immune checkpoint inhibitors. , 2020, European journal of cancer.

[2]  D. Lasserson,et al.  Ambulatory emergency oncology: A key tenet of future emergency oncology care , 2020, International journal of clinical practice.

[3]  F. Hodi,et al.  Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints. , 2018, Endocrine reviews.

[4]  R. Sullivan,et al.  High‐dose glucocorticoids for the treatment of ipilimumab‐induced hypophysitis is associated with reduced survival in patients with melanoma , 2018, Cancer.

[5]  D. Lasserson,et al.  What is the evidence base for ambulatory care for acute medical illness? , 2018, Acute medicine.

[6]  M. Atkins,et al.  The Current Understanding of the Endocrine Effects From Immune Checkpoint Inhibitors and Recommendations for Management , 2018, JNCI cancer spectrum.

[7]  J. Larkin,et al.  SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Acute management of the endocrine complications of checkpoint inhibitor therapy , 2018, Endocrine connections.

[8]  T. Cooksley,et al.  Acute Oncology Care: A narrative review of the acute management of neutropenic sepsis and immune-related toxicities of checkpoint inhibitors. , 2017, European journal of internal medicine.

[9]  D. Kyriacou,et al.  Trends in Adult Cancer–Related Emergency Department Utilization: An Analysis of Data From the Nationwide Emergency Department Sample , 2017, JAMA oncology.

[10]  K. Kerr,et al.  Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  K. Kerr,et al.  Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  Charles R. Thomas,et al.  An Inflection Point in the Evolution of Oncologic Emergency Medicine. , 2016, Annals of emergency medicine.

[13]  P. Chanson,et al.  Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  T. Cooksley,et al.  Emergency oncology: development, current position and future direction in the USA and UK , 2016, Supportive Care in Cancer.